Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Arcoral Tab
- Development stage
- Unknown
- Lead developer
- EUSA Pharma
- Administration
- Oral
01
Overview
Arcoral Tab is a topical oral effervescent tablet formulation with the same active ingredients as the oral rinse Caphosol, designed to generate a supersaturated calcium phosphate solution in the mouth for supportive care in oncology and other conditions associated with reduced salivary flow. It contains high concentrations of calcium and phosphate ions that lubricate the oral, tongue, and oropharyngeal mucosa, enhance mineralization, and help maintain integrity of the oral cavity, thereby alleviating xerostomia, hyposalivation, and oral mucositis associated with radiotherapy, surgery, Sjögren’s syndrome, or salivary gland obstruction.[1][11]
- Brand names
- Arcoral Tab
- Other names
- Arcoral
Beyond the preview
Go deeper on Arcoral Tab.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Arcoral Tab.